Another similar combinational serum-based biomarker study involving the analysis of CA125, CEA, CY211, SCC, and NSE established the role of high serum levels of CA125 and CEA in the screening of NSCLC [106]. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.